Trials / Completed
CompletedNCT01757873
Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Z160 in Subjects With Postherpetic Neuralgia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 144 (actual)
- Sponsor
- Zalicus · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will compare Z160 and placebo in patients with Postherpetic Neuralgia for safety and efficacy for a period of 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Z160 | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2012-12-31
- Last updated
- 2013-12-12
Locations
53 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01757873. Inclusion in this directory is not an endorsement.